Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence.

Ourania Batsi; Ioanna Giannopoulou; Ioannis Nesseris; Christos Valavanis; Hariklia Gakiopoulou; Efstratios S Patsouris; Petroula Arapandoni-Dadioti; Andreas C Lazaris

首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence.

【24h】

Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence.

机译：CXCL12-CXCR4轴和VEGFR3在原发性尿路上皮癌及其复发中的免疫组织化学评估。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

CXCL12 and CXCR4 expression was related to adverse prognostic markers in urothelial bladder carcinoma through their association with grade and pT stage both in PC and RC. The CXCL12-CXCR4 axis may influence the expression of VEGFR3 in urothelial bladder carcinoma and promote tumor recurrence.

机译：CXCL12和CXCR4的表达与尿路上皮膀胱癌的不良预后标志物有关，因为它们与PC和RC中的分级和pT分期相关。 CXCL12-CXCR4轴可能会影响尿路上皮膀胱癌中VEGFR3的表达并促进肿瘤复发。

著录项

来源
《Anticancer Research: International Journal of Cancer Research and Treatment》 |2014年第7期|共6页
作者
Ourania Batsi; Ioanna Giannopoulou; Ioannis Nesseris; Christos Valavanis; Hariklia Gakiopoulou; Efstratios S Patsouris; Petroula Arapandoni-Dadioti; Andreas C Lazaris;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence. [J] . Ourania Batsi, Ioanna Giannopoulou, Ioannis Nesseris, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第7期

机译：CXCL12-CXCR4轴和VEGFR3在原发性尿路上皮癌及其复发中的免疫组织化学评估。
2. Prognostic and clinicopathologic value of ki-67 and profilin 1 immunohistochemical expression in primary pT1 urothelial bladder cancer [J] . Meftun Culpan, Turgay Turan, Sidika Seyma Ozkanli, Journal of Cancer Research and Therapeutics . 2021,第2期

机译：KI-67的预后和临床病理值和初级PT1尿路上皮癌中的免疫组化表达
3. Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer. [J] . Loibl S, Strank C, von Minckwitz G, The Breast : . 2005,第3期

机译：免疫组织化学评估内皮细胞一氧化氮合酶表达的原发性乳腺癌。
4. Automated evaluation of HER-2/neu immunohistochemical expression in breast cancer using digital microscopy [C] . Gavrielides, M.A., Masmoudi, Power Electronics and Motion Control Conference, 2008 13th International . 2008

机译：使用数字显微镜自动评估乳腺癌中的HER-2 / neu免疫组织化学表达
5. Using imputed microRNA regulation based on weighted ranked expression and putative microRNA targets and analysis of variance to select microRNAs for predicting prostate cancer recurrence. [D] . Wang, Qi. 2014

机译：使用基于加权排名表达和推定的microRNA靶标的估算microRNA调控以及方差分析来选择可预测前列腺癌复发的microRNA。
6. Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study [O] . Livia Florianova, Bin Xu, Samer Traboulsi, 2015

机译：膀胱尿路上皮癌中RNA结合基序蛋白3表达的评估：免疫组化研究
7. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence. [O] . Schultz I.J., Kiemeney L.A.L.M., Willems J.L., 2006

机译：浅表尿路上皮细胞癌患者膀胱冲洗液中Survivin和MKI67 mRNA的表达与肿瘤的分期和等级相关，但不能预测肿瘤的复发。

Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence.

摘要

著录项

相似文献

相关主题

期刊订阅